Alleanza Contro il Cancro
In research, Alleanza Contro il Cancro stands highest in Life Sciences (#1,424 of 14,347 worldwide), Medicine (#2,103 of 17,978 worldwide) and Health Sciences (#2,774 of 20,462 worldwide), over all time.
- World rank, all time
- #3,901 of 42,892
- Rank in Italy
- #139 of 969
- Research works
- 2.8k ▼ 83% vs 2013–17
- Citations
- 77k 27.9 per fractional work
- Top-10% rate
- 16.2% record average 16.5%
- Open access
- 16% world 28%
What is Alleanza Contro il Cancro known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| Life SciencesDomain | #1,424 of 14,347 | 16.8% | 849 | |
| MedicineField | #2,103 of 17,978 | 11.0% | 1,640 | |
| Health SciencesDomain | #2,774 of 20,462 | 10.9% | 1,691 | |
| Immunology and MicrobiologyField | #652 of 1,980 | 23.3% | 246 | |
| ImmunologySubfield | #583 of 1,394 | 24.1% | 229 | |
| Biochemistry, Genetics and Molecular BiologyField | #3,417 of 7,814 | 14.7% | 535 | |
| OncologySubfield | #1,058 of 1,852 | 10.8% | 292 | |
| Molecular BiologySubfield | #2,942 of 4,961 | 14.9% | 261 | |
| SurgerySubfield | #2,608 of 4,227 | 7.9% | 226 | |
| Pulmonary and Respiratory MedicineSubfield | #1,935 of 2,717 | 9.4% | 174 |
Each strip is that field’s whole ranked pool, with the notch where Alleanza Contro il Cancro sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Earth and Planetary Sciences, 6.5×. Every wedge is a field page.
- Earth and Planetary Sciences 6.5×
- Nursing 4.0×
- Arts and Humanities 3.5×
- Medicine 2.4×
- Pharmacology, Toxicology and Pharmaceutics 1.9×
- Immunology and Microbiology 1.7×
- Biochemistry, Genetics and Molecular Biology 1.7×
- Business, Management and Accounting 1.1×
- Economics, Econometrics and Finance 0.8×
- Materials Science 0.7×
- Psychology 0.6×
- Neuroscience 0.5×
- Engineering 0.4×
- Social Sciences 0.3×
- Agricultural and Biological Sciences 0.2×
- Mathematics 0.1×
- Computer Science 0.0×
Who are the top researchers at Alleanza Contro il Cancro?
Ranked on the composite score, Lazzaro Repetto, Marco Benasso and Claudia Bolognesi lead among researchers whose main affiliation is Alleanza Contro il Cancro.
- 1 Lazzaro Repetto Italy · #82,025 worldwide 353 citations · 28 works
- 2 Marco Benasso Italy · #104,574 worldwide 496 citations · 22 works
- 3 Claudia Bolognesi Italy · #124,602 worldwide 153 citations · 29 works
- 4 Paolo Bruzzi Italy · #134,307 worldwide 291 citations · 66 works
- 5 C. Aschele Italy · #163,656 worldwide 149 citations · 29 works
- 6 Riccardo Rosso Italy · #170,888 worldwide 175 citations · 27 works
- 7 Roberto Fiocca Italy · #180,540 worldwide 187 citations · 66 works
- 8 Domenico Franco Merlo Italy · #182,494 worldwide 116 citations · 50 works
- 9 Walter Giaretti Italy · #303,264 worldwide 120 citations · 18 works
- 10 Francesco Boccardo Italy · #322,190 worldwide 83 citations · 43 works
Which keywords describe research at Alleanza Contro il Cancro?
By fractional works in all years, weighted toward what it does more of than the world: Chemotherapy, Inflammation, Immunotherapy, Cancer, Radiotherapy, Prognostic Factors, Metastasis and Angiogenesis.
- Nuclear Receptors
- Molecular Characterization
- Metastatic Breast Cancer
- Cancer Immunotherapy
- Neurotoxicity
- Immunity
- Foxp3
- Neoadjuvant Therapy
- Targeted Therapy
- TGF-ß
- Survival Analysis
- Natural Killer Cells
- Autoimmunity
- Breast Cancer
- Clinical Practice Guidelines
- Metastasis
- Prognostic Factors
- Quality of Life
- Cancer
- Chemotherapy
- Inflammation
- Epidemiology
- Immunotherapy
- Radiotherapy
- Treatment
- Angiogenesis
- Genetic Mutations
- Diagnosis
- NK Cell Recognition
- Clinical Trials
- Extracellular Matrix
- Cancer Therapy
- DNA Damage
- CD4+CD25+
- Glycosylation
- Prognosis
- Rituximab
- Therapeutic Targets
- Molecular Subtypes
- Cell Adhesion
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Inflammation234▲ 3.6×74 topics
- Chemotherapy201▲ 10×24 topics
- Epidemiology193▲ 1.73×109 topics
- Cancer164▲ 4.2×49 topics
- Immunotherapy149▲ 8.3×19 topics
- Quality of Life99▲ 2.6×35 topics
- Radiotherapy99▲ 9.4×13 topics
- Prognostic Factors95▲ 7.6×14 topics
- Treatment92▲ 2.6×43 topics
- Metastasis91▲ 9.7×12 topics
- Angiogenesis90▲ 7.9×16 topics
- Clinical Practice Guidelines84▲ 5.4×14 topics
- Genetic Mutations79▲ 5.5×22 topics
- Breast Cancer78▲ 10×11 topics
- Diagnosis74▲ 2.6×36 topics
- Autoimmunity73▲ 13×6 topics
- NK Cell Recognition70▲ 25×1 topic
- Natural Killer Cells70▲ 25×1 topic
- Clinical Trials70▲ 4.0×15 topics
- Survival Analysis68▲ 9.1×7 topics
- Extracellular Matrix63▲ 9.5×7 topics
- TGF-ß63▲ 13×4 topics
- Cancer Therapy62▲ 3.6×18 topics
- Targeted Therapy62▲ 10×5 topics
- DNA Damage61▲ 16×4 topics
- Neoadjuvant Therapy57▲ 9.3×5 topics
- CD4+CD25+56▲ 27×1 topic
- Foxp356▲ 27×1 topic
- Glycosylation55▲ 8.9×3 topics
- Immunity53▲ 5.7×11 topics
- Prognosis52▲ 5.8×9 topics
- Neurotoxicity51▲ 10×6 topics
- Rituximab51▲ 11×4 topics
- Cancer Immunotherapy50▲ 13×3 topics
- Therapeutic Targets50▲ 7.7×7 topics
- Metastatic Breast Cancer49▲ 27×2 topics
- Molecular Subtypes48▲ 20×3 topics
- Molecular Characterization47▲ 9.2×6 topics
- Cell Adhesion44▲ 18×3 topics
- Nuclear Receptors43▲ 8.5×5 topics
Which research topics does Alleanza Contro il Cancro publish most on?
By volume in 2022–2025: Historical and Architectural Studies, Ancient Mediterranean Archaeology and History, Cancer survivorship and care and Advances in Oncology and Radiotherapy.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Historical and Architectural Studies Archeology 0 works
- 2 Ancient Mediterranean Archaeology and History Archeology 0 works
- 3 Cancer survivorship and care Oncology 0 works
- 4 Advances in Oncology and Radiotherapy Radiology, Nuclear Medicine and Imaging 0 works
- 5 COVID-19 and healthcare impacts Oncology 0 works
- 6 3D Surveying and Cultural Heritage Geology 0 works
- 7 BRCA gene mutations in cancer Genetics 0 works
- 8 Cancer Genomics and Diagnostics Cancer Research 0 works
- 9 Mast cells and histamine Immunology 0 works
- 10 Additive Manufacturing and 3D Printing Technologies Automotive Engineering 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Alleanza Contro il Cancro's research output changed?
Output in 2018–2022 was 83% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Rome
- Sapienza University of Rome
- University of Rome Tor Vergata
- Istituti di Ricovero e Cura a Carattere Scientifico
- National Research Council
- Roma Tre University
- Istituto Superiore di Sanità
- National Agency for New Technologies, Energy and Sustainable Economic Development
- Agostino Gemelli University Polyclinic
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.